| Melissa L Belanger Psyd Llc | |
|
45-955 Kamehameha Hwy Ste 306 Kaneohe HI 96744-3292 | |
| (808) 247-7900 | |
| (808) 254-4526 |
| Full Name | Melissa L Belanger Psyd Llc |
|---|---|
| Speciality | Clinic/Center |
| Location | 45-955 Kamehameha Hwy Ste 306, Kaneohe, Hawaii |
| Authorized Official Name and Position | Melissa Lee Belanger (PRESIDENT) |
| Authorized Official Contact | 8082477900 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Melissa L Belanger Psyd Llc Po Box 1451 Kailua HI 96734-1451 Ph: (808) 247-7900 | Melissa L Belanger Psyd Llc 45-955 Kamehameha Hwy Ste 306 Kaneohe HI 96744-3292 Ph: (808) 247-7900 |
| NPI Number | 1205121373 |
|---|---|
| Provider Enumeration Date | 06/16/2011 |
| Last Update Date | 06/16/2011 |
| Medicare PECOS PAC ID | 8426227125 |
|---|---|
| Medicare Enrollment ID | O20110815000676 |
News Archive
VITAS, the nation's leading hospice provider, is now serving patients with life-limiting diagnoses and their families in the greater Columbus area, including those in Delaware, Fairfield, Franklin, Licking, Madison, Pickaway and Union counties. VITAS also provides quality, compassionate end-of-life care in Ohio to patients and families in Cleveland, Cincinnati and Dayton.
BD (Becton, Dickinson and Company), a leading global medical technology company, announced today the launch in the UK and Ireland of BD Micro-Fine Ultra with 5-bevel needle technology, clinically demonstrated to improve injection comfort for diabetes patients, and enhancing the injection advantages of the current BD Micro-Fine+ Pen Needle.
Almost two-thirds of females attending a general urology practice reported that they suffered from sexual dysfunction, according to a paper in the August issue of BJUI. Dysfunction rose with age in all categories except orgasm, with more than half of women aged from 18 to 30 reporting orgasm problems, significantly higher than women aged 31 to 54.
Extended exposure to the psoriasis medication etanercept does not appear to cause more infections or adverse events than placebo, and improvements in several measures of disease severity were observed for up to 96 weeks of therapy, according to a study in the June issue of Archives of Dermatology.
"A group of researchers led by Novartis AG have discovered novel malaria compounds that may prove to be more efficient than currently available treatments and could be used as a prophylactic," the Wall Street Journal reports.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205121373 | NPI | - | NPPES |
| 55627701 | Medicaid | HI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QM0801X | Clinic/center - Mental Health (including Community Mental Health Center) | PSY 753 (Hawaii) | Primary |
| Provider Name | Melissa L Belanger |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1083635155 PECOS PAC ID: 8426036872 Enrollment ID: I20040712000710 |
News Archive
VITAS, the nation's leading hospice provider, is now serving patients with life-limiting diagnoses and their families in the greater Columbus area, including those in Delaware, Fairfield, Franklin, Licking, Madison, Pickaway and Union counties. VITAS also provides quality, compassionate end-of-life care in Ohio to patients and families in Cleveland, Cincinnati and Dayton.
BD (Becton, Dickinson and Company), a leading global medical technology company, announced today the launch in the UK and Ireland of BD Micro-Fine Ultra with 5-bevel needle technology, clinically demonstrated to improve injection comfort for diabetes patients, and enhancing the injection advantages of the current BD Micro-Fine+ Pen Needle.
Almost two-thirds of females attending a general urology practice reported that they suffered from sexual dysfunction, according to a paper in the August issue of BJUI. Dysfunction rose with age in all categories except orgasm, with more than half of women aged from 18 to 30 reporting orgasm problems, significantly higher than women aged 31 to 54.
Extended exposure to the psoriasis medication etanercept does not appear to cause more infections or adverse events than placebo, and improvements in several measures of disease severity were observed for up to 96 weeks of therapy, according to a study in the June issue of Archives of Dermatology.
"A group of researchers led by Novartis AG have discovered novel malaria compounds that may prove to be more efficient than currently available treatments and could be used as a prophylactic," the Wall Street Journal reports.
› Verified 7 days ago
News Archive
VITAS, the nation's leading hospice provider, is now serving patients with life-limiting diagnoses and their families in the greater Columbus area, including those in Delaware, Fairfield, Franklin, Licking, Madison, Pickaway and Union counties. VITAS also provides quality, compassionate end-of-life care in Ohio to patients and families in Cleveland, Cincinnati and Dayton.
BD (Becton, Dickinson and Company), a leading global medical technology company, announced today the launch in the UK and Ireland of BD Micro-Fine Ultra with 5-bevel needle technology, clinically demonstrated to improve injection comfort for diabetes patients, and enhancing the injection advantages of the current BD Micro-Fine+ Pen Needle.
Almost two-thirds of females attending a general urology practice reported that they suffered from sexual dysfunction, according to a paper in the August issue of BJUI. Dysfunction rose with age in all categories except orgasm, with more than half of women aged from 18 to 30 reporting orgasm problems, significantly higher than women aged 31 to 54.
Extended exposure to the psoriasis medication etanercept does not appear to cause more infections or adverse events than placebo, and improvements in several measures of disease severity were observed for up to 96 weeks of therapy, according to a study in the June issue of Archives of Dermatology.
"A group of researchers led by Novartis AG have discovered novel malaria compounds that may prove to be more efficient than currently available treatments and could be used as a prophylactic," the Wall Street Journal reports.
› Verified 7 days ago
Mauli Ola Therapy Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 46-022 Alaloa St, Kaneohe, HI 96744 Phone: 808-201-8282 | |
Healing Touch Integrative Wellness & Counseling Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 45-329 Puali St, Kaneohe, HI 96744 Phone: 240-601-5272 | |
Rolling Wave Aba, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 45-143c William Henry Rd # C, Kaneohe, HI 96744 Phone: 808-728-2175 | |
C. Kimo Chan, M.d., Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 46-271 Haiku Rd, Kaneohe, HI 96744 Phone: 808-235-4204 | |
Dr Mary C Horn Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 45-955 Kamehameha Hwy, #306, Kaneohe, HI 96744 Phone: 808-247-2961 Fax: 808-247-2962 | |
New Heart Christian Counseling Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 45-503 Likelike Hwy, Kaneohe, HI 96744 Phone: 808-688-8668 Fax: 808-490-0944 | |
State Of Hawaii Department Of Health Adult Mental Health Division Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 45-710 Keaahala Rd, Kaneohe, HI 96744 Phone: 808-236-8580 Fax: 808-236-8590 |